Question 1

Which adverse effects associated with levodopa therapy would support the nursing diagnosis risk for injury?

Accepted Answer

A)  Nausea and vomiting 
B)  Orthostatic hypotension 
C)  Anorexia and depression 
D)  Tachycardia and palpitations 
A)  Nausea and vomiting 
B)  Orthostatic hypotension 
C)  Anorexia and depression 
D)  Tachycardia and palpitations B

Question 2

What is the pharmacologic action of entacapone,a potent catechol O methyl transferase (COMT)inhibitor?

Accepted Answer

A)  Slows the deterioration of dopaminergic nerve cells. 
B)  Inhibits the relative excess of dopaminergic activity. 
C)  Reduces the destruction of dopamine in peripheral tissues. 
D)  Enhances the cholinergic symptoms of Parkinson's disease. 
A)  Slows the deterioration of dopaminergic nerve cells. 
B)  Inhibits the relative excess of dopaminergic activity. 
C)  Reduces the destruction of dopamine in peripheral tissues. 
D)  Enhances the cholinergic symptoms of Parkinson's disease. C

Question 3

The nurse is teaching a patient with Parkinson's disease about levodopa.Which statement by the nurse is accurate regarding drug administration?

Accepted Answer

A)  "Take this medication in between meals." 
B)  "Take this medication at bedtime to prevent dizziness." 
C)  "Take this medication when your tremors get worse." 
D)  "Take this medication with food or antacids to reduce GI upset." 
A)  "Take this medication in between meals." 
B)  "Take this medication at bedtime to prevent dizziness." 
C)  "Take this medication when your tremors get worse." 
D)  "Take this medication with food or antacids to reduce GI upset." D

Question 4

Which vitamin will reduce the therapeutic effects of levodopa?

Accepted Answer

A)  A 
B)  B6 
C)  C 
D)  D 
A)  A 
B)  B6 
C)  C 
D)  D

Question 5

Which cholinergic symptoms of Parkinson's disease are reduced with anticholinergic drugs?

Accepted Answer

A)  Cognitive impairments 
B)  Rigidity 
C)  Tremors and drooling 
D)  Postural abnormalities 
A)  Cognitive impairments 
B)  Rigidity 
C)  Tremors and drooling 
D)  Postural abnormalities

Question 6

When a patient taking a monoamine oxidase B inhibitor receives his dietary tray,the nurse knows to remove the:

Accepted Answer

A)  cheese. 
B)  eggs. 
C)  bread. 
D)  coffee. 
A)  cheese. 
B)  eggs. 
C)  bread. 
D)  coffee.

Question 7

The nurse is assessing an older patient with Parkinson's disease who was started on entacapone 1 week ago.The patient has a history of coronary artery disease and takes an antihypertensive and aspirin.Which information would support the need for a reduction in medication dosage by the healthcare provider?

Accepted Answer

A)  Constipation 
B)  Brownish orange urine 
C)  Drowsiness 
D)  Dizziness 
A)  Constipation 
B)  Brownish orange urine 
C)  Drowsiness 
D)  Dizziness

Question 8

Parkinson's disease has which characteristic symptom(s)? (Select all that apply.)

Accepted Answer

A)  Muscle tremors 
B)  Posture alterations 
C)  Muscle flaccidity 
D)  Tachycardia 
E)  Slow body movement 
A)  Muscle tremors 
B)  Posture alterations 
C)  Muscle flaccidity 
D)  Tachycardia 
E)  Slow body movement

Question 9

The nurse is preparing to begin administration of apomorphine to a patient.Before administering,the nurse will perform a baseline assessment of the patient's: (Select all that apply.)

Accepted Answer

A)  mobility. 
B)  orientation. 
C)  intellectual ability. 
D)  alertness. 
E)  vital signs. 
A)  mobility. 
B)  orientation. 
C)  intellectual ability. 
D)  alertness. 
E)  vital signs.

Question 10

Dopamine agonists have been linked with which adverse effects in patients with Parkinson's disease?

Accepted Answer

A)  Oculogyric crisis 
B)  Tardive dyskinesia 
C)  Sudden sleep events 
D)  Akathisia 
A)  Oculogyric crisis 
B)  Tardive dyskinesia 
C)  Sudden sleep events 
D)  Akathisia

Question 11

A patient taking rasagiline is assessed by the nurse to have a lasting significant increase in blood pressure.When reviewing the patient's current list of medications,the nurse decides to hold the next dose of:

Accepted Answer

A)  dextromethorphan. 
B)  levodopa. 
C)  ciprofloxacin. 
D)  Valium. 
A)  dextromethorphan. 
B)  levodopa. 
C)  ciprofloxacin. 
D)  Valium.

Question 12

The nurse is providing information to a patient recently prescribed entacapone.Which statement is correct?

Accepted Answer

A)  This medication is not to be taken with carbidopa levodopa. 
B)  Dosage is adjusted according to the patient's response. 
C)  There will be fewer incidences of dopaminergic effects,such as confusion. 
D)  This medication increases the production of dopamine in the brain. 
A)  This medication is not to be taken with carbidopa levodopa. 
B)  Dosage is adjusted according to the patient's response. 
C)  There will be fewer incidences of dopaminergic effects,such as confusion. 
D)  This medication increases the production of dopamine in the brain.

Question 13

The nurse is providing education to a patient recently placed on selegiline disintegrating tablets.Which statement by the patient indicates a need for further teaching?

Accepted Answer

A)  "This medication will help slow the development of symptoms." 
B)  "I will place the tablet on my tongue before breakfast." 
C)  "I may need to use a stool softener for constipation." 
D)  "I should not push the tablet through the foil." 
A)  "This medication will help slow the development of symptoms." 
B)  "I will place the tablet on my tongue before breakfast." 
C)  "I may need to use a stool softener for constipation." 
D)  "I should not push the tablet through the foil."

Question 14

What is the rationale for administering levodopa instead of dopamine for treatment of Parkinson's disease?

Accepted Answer

A)  Dopamine does not cross the blood-brain barrier when administered orally. 
B)  Levodopa is much less expensive. 
C)  The half-life of dopamine is too short. 
D)  Dopamine has too many reactions with other medications. 
A)  Dopamine does not cross the blood-brain barrier when administered orally. 
B)  Levodopa is much less expensive. 
C)  The half-life of dopamine is too short. 
D)  Dopamine has too many reactions with other medications.

Exam 14: Drugs Used to Treat Neurodegenerative Disorders

Which adverse effects associated with levodopa therapy would support the nursing diagnosis risk for injury?

What is the pharmacologic action of entacapone,a potent catechol O methyl transferase (COMT)inhibitor?

The nurse is teaching a patient with Parkinson's disease about levodopa.Which statement by the nurse is accurate regarding drug administration?

Which vitamin will reduce the therapeutic effects of levodopa?

Which cholinergic symptoms of Parkinson's disease are reduced with anticholinergic drugs?

When a patient taking a monoamine oxidase B inhibitor receives his dietary tray,the nurse knows to remove the:

Parkinson's disease has which characteristic symptom(s)? (Select all that apply.)

The nurse is preparing to begin administration of apomorphine to a patient.Before administering,the nurse will perform a baseline assessment of the patient's: (Select all that apply.)

Dopamine agonists have been linked with which adverse effects in patients with Parkinson's disease?

A patient taking rasagiline is assessed by the nurse to have a lasting significant increase in blood pressure.When reviewing the patient's current list of medications,the nurse decides to hold the next dose of:

The nurse is providing information to a patient recently prescribed entacapone.Which statement is correct?

The nurse is providing education to a patient recently placed on selegiline disintegrating tablets.Which statement by the patient indicates a need for further teaching?

What is the rationale for administering levodopa instead of dopamine for treatment of Parkinson's disease?

Drug Definitions, standards, and Information Sources

Basic Principles of Drug Action and Drug Interactions

Drug Action Across the Life Span

The Nursing Process and Pharmacology

Patient Education to Promote Health

Principles of Medication Administration and Medication Safety

Percutaneous Administration

Enteral Administration

Parenteral Administration: Safe Preparation of Parenteral Medications

Parenteral Administration: Intradermal, subcutaneous, and Intramuscular Routes

Parenteral Administration: Intravenous Route

Drugs Affecting the Autonomic Nervous System

Drugs Used for Sleep

Drugs Used for Anxiety Disorders

Drugs Used for Depressive and Bipolar Disorders

Drugs Used for Psychoses

Drugs Used for Seizure Disorders

Drugs Used for Pain Management

Introduction to Cardiovascular Disease and Metabolic Syndrome

Drugs Used to Treat Dyslipidemias

Drugs Used to Treat Hypertension

Drugs Used to Treat Dysrhythmias

Drugs Used to Treat Angina Pectoris

Drugs Used to Treat Peripheral Vascular Disease

Drugs Used to Treat Thromboembolic Disorders

Drugs Used to Treat Heart Failure

Drugs Used for Diuresis

Drugs Used to Treat Upper Respiratory Disease

Drugs Used to Treat Lower Respiratory Disease

Drugs Used to Treat Oral Disorders

Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Disease

Drugs Used to Treat Nausea and Vomiting

Drugs Used to Treat Constipation and Diarrhea

Drugs Used to Treat Diabetes Mellitus

Drugs Used to Treat Thyroid Disease

Corticosteroids

Gonadal Hormones

Drugs Used in Obstetrics

Drugs Used in Mens and Womens Health

Drugs Used to Treat Disorders of the Urinary System

Drugs Used to Treat Glaucoma and Other Eye Disorders

Drugs Used to Treat Cancer

Drugs Used to Treat the Musculoskeletal System

Antimicrobial Agents

Nutrition

Herbal and Dietary Supplement Therapy

Substance Abuse

Filters